Regulatory effects of ghrelin on endoplasmic reticulum stress, oxidative stress, and autophagy: Therapeutic potential

Neuropeptides. 2021 Feb:85:102112. doi: 10.1016/j.npep.2020.102112. Epub 2020 Dec 11.

Abstract

Ghrelin is a regulatory peptide that is the endogenous ligand of the growth hormone secretagogue 1a (GHS-R1a) which belongs to the G protein-coupled receptor family. Ghrelin and GHS-R1a are widely expressed in the central and peripheral tissues and play therapeutic potential roles in the cytoprotection of many internal organs. Endoplasmic reticulum stress (ERS), oxidative stress, and autophagy dysfunction, which are involved in various diseases. In recent years, accumulating evidence has suggested that ghrelin exerts protective effects by regulating ERS, oxidative stress, and autophagy in diverse diseases. This review article summarizes information about the roles of the ghrelin system on ERS, oxidative stress, and autophagy in multiple diseases. It is suggested that ghrelin positively affects the treatment of diseases and may be considered as a therapeutic drug in many illnesses.

Keywords: Autophagy; Diseases; Endoplasmic reticulum stress; Ghrelin; Oxidative stress.

Publication types

  • Review

MeSH terms

  • Animals
  • Autophagy / drug effects*
  • Brain / drug effects*
  • Brain / metabolism*
  • Endoplasmic Reticulum Stress / drug effects*
  • Ghrelin / metabolism*
  • Ghrelin / therapeutic use*
  • Humans
  • Neurons / drug effects
  • Neurons / metabolism
  • Oxidative Stress / drug effects*
  • Signal Transduction

Substances

  • Ghrelin